Literature DB >> 6123788

Melatonin and cortisol levels in psychiatric illness.

L Wetterberg, B Aperia, J Beck-Friis, B F Kjellman, J G Ljunggren, A Nilsonne, U Petterson, A Tham, F Undén.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6123788     DOI： 10.1016/s0140-6736(82)91720-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Circadian profile of serum melatonin in patients with Cushing's syndrome or acromegaly.

Authors:  M Terzolo; A Piovesan; A Alì; A Codegone; A Pia; G Reimondo; M Torta; P Paccotti; G Borretta; A Angeli
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

Review 2.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

3.  Metyrapone: an agent for melatonin as well as ACTH and cortisol secretion.

Authors:  K Brismar; S Werner; M Thorén; L Wetterberg
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

4.  Urinary melatonin in depression.

Authors:  A V Rao; S P Devi; V Srinivasan
Journal:  Indian J Psychiatry       Date:  1983-07       Impact factor: 1.759

5.  Salivary Melatonin in Relation to Depressive Symptom Severity in Young Adults.

Authors:  Isak Sundberg; Mia Ramklint; Mats Stridsberg; Fotios C Papadopoulos; Lisa Ekselius; Janet L Cunningham
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.